Our study is based on a large number of NSCLC patients, using IHC, RT-PCR, and NGS methods for detection and comparison of the EML4-ALK gene, providing a basis for rational selection of clinical applications. The gene discussed is ALK; the disease is non-small cell lung carcinoma.